HYALURONIC ACID SODIUM SALT 2% / MOMETASONE FUROATE 0.1% / NIACINAMIDE 4%
- Product NDC
- 72934-2098
- 11-digit product format
- 729342098
- Labeler code
- 72934
- Product ID
- 72934-2098_8967cd2b-c0a5-8df1-e053-2a95a90a3670
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- HYALURONIC ACID SODIUM SALT 2% / MOMETASONE FUROATE 0.1% / NIACINAMIDE 4%
- Dosage form
- CREAM
- Route
- TOPICAL
- Labeler
- Sincerus Florida, LLC
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start
- 2019-05-21
- Marketing end
- 0000-00-00
- Substance
- HYALURONIC ACID; MOMETASONE FUROATE; NIACINAMIDE
- Active strength
- 2 g/100g; g/100g; g/100g
- Pharmacologic classes
- Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Corticosteroid Hormone Receptor Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72934-2098-2 | HYALURONIC ACID SODIUM SALT 2% / MOMETASONE FUROATE 0.1% / NIACINAMIDE 4% | 30 g in 1 BOTTLE, PUMP | CREAM | 30 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72934-2098 | HYALURONIC ACID SODIUM SALT 2% / MOMETASONE FUROATE 0.1% / NIACINAMIDE 4% CREAM [SINCERUS FLORIDA, LLC] | 1 | Legacy NDC, 1 package rows | 20190522_8967cd2b-c0a4-8df1-e053-2a95a90a3670.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Status |
|---|
| 72934-2098-2 | 72934209802 | 30 g in 1 BOTTLE, PUMP | 30 g | Historical |